Thyrotoxicosis and radioiodine therapy: Does the dose matter?

There are 3 treatment options for thyrotoxicosis: Antithyroid drugs, Surgery and radioiodine. The choice of treatment varies geographically. Radioiodine therapy is preferred in the United States. The aim of radioiodine is to destroy sufficient thyroid tissue to cure the hyperthyroidism. There is a l...

Descripción completa

Detalles Bibliográficos
Autor principal: Collier, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603012/
https://www.ncbi.nlm.nih.gov/pubmed/23565364
http://dx.doi.org/10.4103/2230-8210.104025
_version_ 1782263612914532352
author Collier, Andrew
author_facet Collier, Andrew
author_sort Collier, Andrew
collection PubMed
description There are 3 treatment options for thyrotoxicosis: Antithyroid drugs, Surgery and radioiodine. The choice of treatment varies geographically. Radioiodine therapy is preferred in the United States. The aim of radioiodine is to destroy sufficient thyroid tissue to cure the hyperthyroidism. There is a lack of consensus towards what dose of radioiodine should be used. Several methods are used to determine the dose. In our practice we administer 400 MBq to patients with Graves and in patients with large multinodular goiter, we would administer 800 MBq.
format Online
Article
Text
id pubmed-3603012
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36030122013-04-05 Thyrotoxicosis and radioiodine therapy: Does the dose matter? Collier, Andrew Indian J Endocrinol Metab Mini Review There are 3 treatment options for thyrotoxicosis: Antithyroid drugs, Surgery and radioiodine. The choice of treatment varies geographically. Radioiodine therapy is preferred in the United States. The aim of radioiodine is to destroy sufficient thyroid tissue to cure the hyperthyroidism. There is a lack of consensus towards what dose of radioiodine should be used. Several methods are used to determine the dose. In our practice we administer 400 MBq to patients with Graves and in patients with large multinodular goiter, we would administer 800 MBq. Medknow Publications & Media Pvt Ltd 2012-12 /pmc/articles/PMC3603012/ /pubmed/23565364 http://dx.doi.org/10.4103/2230-8210.104025 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Mini Review
Collier, Andrew
Thyrotoxicosis and radioiodine therapy: Does the dose matter?
title Thyrotoxicosis and radioiodine therapy: Does the dose matter?
title_full Thyrotoxicosis and radioiodine therapy: Does the dose matter?
title_fullStr Thyrotoxicosis and radioiodine therapy: Does the dose matter?
title_full_unstemmed Thyrotoxicosis and radioiodine therapy: Does the dose matter?
title_short Thyrotoxicosis and radioiodine therapy: Does the dose matter?
title_sort thyrotoxicosis and radioiodine therapy: does the dose matter?
topic Mini Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603012/
https://www.ncbi.nlm.nih.gov/pubmed/23565364
http://dx.doi.org/10.4103/2230-8210.104025
work_keys_str_mv AT collierandrew thyrotoxicosisandradioiodinetherapydoesthedosematter

Ejemplares similares